Heritage Financial (NASDAQ:HFWA) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Heritage Financial (NASDAQ:HFWA – Free Report) from a sell rating to a hold rating in a research note published on Saturday morning. Several other research firms also recently issued reports on HFWA. Piper Sandler dropped their price objective on shares of Heritage Financial from $35.00 to $34.00 and set […]
Future Money Acquisition (NASDAQ:FMACU) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Future Money Acquisition (NASDAQ:FMACU – Free Report) to a hold rating in a research report report published on Saturday morning. Future Money Acquisition Stock Performance Shares of FMACU stock opened at $10.00 on Friday. Future Money Acquisition has a twelve month low of $9.98 and a twelve month high […]
Roma Green Finance (NASDAQ:ROMA) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Roma Green Finance (NASDAQ:ROMA – Free Report) to a hold rating in a research report sent to investors on Saturday morning. Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Roma Green Finance in a research report on Thursday, January 22nd. One equities research analyst has rated […]
Plus Therapeutics (NASDAQ:PSTV) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Plus Therapeutics (NASDAQ:PSTV – Free Report) to a sell rating in a research report report published on Saturday morning. Several other equities analysts also recently commented on PSTV. D. Boral Capital reiterated a “hold” rating on shares of Plus Therapeutics in a report on Tuesday, March 31st. Lake Street […]
bioAffinity Technologies (NASDAQ:BIAF) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of bioAffinity Technologies (NASDAQ:BIAF – Free Report) to a hold rating in a research report released on Saturday morning. Separately, Weiss Ratings restated a “sell (e+)” rating on shares of bioAffinity Technologies in a report on Wednesday, January 21st. One equities research analyst has rated the stock with a Sell […]
ProFrac (NASDAQ:ACDC) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of ProFrac (NASDAQ:ACDC – Free Report) from a sell rating to a hold rating in a research report report published on Saturday. ACDC has been the topic of a number of other reports. Zacks Research raised shares of ProFrac from a “strong sell” rating to a “hold” rating in a […]
Oceanpal (NASDAQ:SVRN) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Oceanpal (NASDAQ:SVRN – Free Report) to a hold rating in a research note published on Saturday. Oceanpal Trading Up 21.1% Shares of SVRN stock opened at $9.58 on Friday. Oceanpal has a 52-week low of $3.12 and a 52-week high of $1,585.00. About Oceanpal (Get Free Report) OceanPal Inc […]
Rapid7 (NASDAQ:RPD) Upgraded to “Buy” at Wall Street Zen
Wall Street Zen upgraded shares of Rapid7 (NASDAQ:RPD – Free Report) from a hold rating to a buy rating in a research report sent to investors on Monday morning. A number of other research firms have also weighed in on RPD. Mizuho lowered their price target on shares of Rapid7 from $16.00 to $12.00 and […]
Sigma Lithium (NASDAQ:SGML) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Sigma Lithium (NASDAQ:SGML – Free Report) from a sell rating to a hold rating in a research note issued to investors on Saturday. Several other research analysts have also recently commented on the company. Canaccord Genuity Group raised Sigma Lithium from a “hold” rating to a “buy” rating in […]
GDS (NASDAQ:GDS) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of GDS (NASDAQ:GDS – Free Report) from a sell rating to a hold rating in a research report released on Saturday morning. Several other equities research analysts have also issued reports on the company. Morgan Stanley reaffirmed an “overweight” rating and issued a $64.00 price objective on shares of GDS […]
FibroBiologics (NASDAQ:FBLG) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of FibroBiologics (NASDAQ:FBLG – Free Report) to a sell rating in a research note published on Saturday morning. Several other equities research analysts also recently issued reports on FBLG. Weiss Ratings reiterated a “sell (e+)” rating on shares of FibroBiologics in a report on Thursday, January 22nd. D. Boral Capital […]
Omeros (NASDAQ:OMER) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Omeros (NASDAQ:OMER – Free Report) from a sell rating to a hold rating in a report issued on Saturday morning. A number of other equities analysts also recently commented on OMER. D. Boral Capital reiterated a “buy” rating and issued a $36.00 price target on shares of Omeros in […]
Belite Bio (NASDAQ:BLTE) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Belite Bio (NASDAQ:BLTE – Free Report) from a sell rating to a hold rating in a report published on Saturday morning. BLTE has been the subject of several other reports. Benchmark reissued a “buy” rating on shares of Belite Bio in a research report on Tuesday, March 3rd. Cantor […]
Aeva Technologies (NASDAQ:AEVA) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Aeva Technologies (NASDAQ:AEVA – Free Report) from a sell rating to a hold rating in a research note released on Saturday morning. Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Aeva Technologies in a research report on Friday, March 27th. Three equities research analysts have rated […]
Comtech Telecommunications (NASDAQ:CMTL) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Comtech Telecommunications (NASDAQ:CMTL – Free Report) from a sell rating to a hold rating in a report released on Saturday morning. Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Comtech Telecommunications in a research note on Wednesday, January 21st. One investment analyst has rated the stock […]
Tenable (NASDAQ:TENB) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Tenable (NASDAQ:TENB – Free Report) from a buy rating to a strong-buy rating in a report issued on Saturday. A number of other research analysts have also issued reports on TENB. Wedbush cut their price target on shares of Tenable from $42.00 to $32.00 and set an “outperform” rating […]
Seanergy Maritime (NASDAQ:SHIP) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Seanergy Maritime (NASDAQ:SHIP – Free Report) from a buy rating to a strong-buy rating in a research report report published on Saturday morning. A number of other research firms have also weighed in on SHIP. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Seanergy Maritime in a […]
Vor Biopharma (NASDAQ:VOR) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Vor Biopharma (NASDAQ:VOR – Free Report) from a strong sell rating to a hold rating in a research note issued to investors on Saturday morning. A number of other equities analysts also recently weighed in on the stock. Jefferies Financial Group initiated coverage on shares of Vor Biopharma in […]
Southern First Bancshares (NASDAQ:SFST) Upgraded to Buy at Wall Street Zen
Wall Street Zen upgraded shares of Southern First Bancshares (NASDAQ:SFST – Free Report) from a hold rating to a buy rating in a report issued on Sunday. Other research analysts have also recently issued research reports about the stock. Piper Sandler lifted their price objective on shares of Southern First Bancshares from $54.00 to $64.00 […]
Leonardo DRS (NASDAQ:DRS) Upgraded to “Buy” at Wall Street Zen
Wall Street Zen upgraded shares of Leonardo DRS (NASDAQ:DRS – Free Report) from a hold rating to a buy rating in a report released on Saturday morning. Several other research analysts have also commented on the stock. Truist Financial set a $59.00 price objective on shares of Leonardo DRS in a research note on Wednesday, […]
TuHURA Biosciences (NASDAQ:HURA) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of TuHURA Biosciences (NASDAQ:HURA – Free Report) from a sell rating to a hold rating in a research note issued to investors on Monday morning. A number of other research analysts have also recently issued reports on HURA. HC Wainwright reaffirmed a “buy” rating and issued a $10.00 target price […]
Safe and Green Development (NASDAQ:RENX) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Safe and Green Development (NASDAQ:RENX – Free Report) to a sell rating in a research report released on Monday. Safe and Green Development Trading Up 46.6% NASDAQ:RENX opened at $2.61 on Monday. The company has a market cap of $6.06 million, a PE ratio of -0.58 and a beta […]
First Northwest Bancorp (NASDAQ:FNWB) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of First Northwest Bancorp (NASDAQ:FNWB – Free Report) from a sell rating to a hold rating in a research report released on Sunday. Several other research analysts have also commented on the stock. Weiss Ratings reiterated a “sell (d-)” rating on shares of First Northwest Bancorp in a research note […]
Spero Therapeutics (NASDAQ:SPRO) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Spero Therapeutics (NASDAQ:SPRO – Free Report) from a hold rating to a strong-buy rating in a research note released on Sunday morning. Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Spero Therapeutics in a research report on Thursday, January 22nd. One analyst has rated the stock […]
Healthcare Services Group (NASDAQ:HCSG) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Healthcare Services Group (NASDAQ:HCSG – Free Report) from a hold rating to a buy rating in a report issued on Sunday morning. A number of other research analysts have also commented on HCSG. Royal Bank Of Canada began coverage on shares of Healthcare Services Group in a research report […]
Uranium Royalty (NASDAQ:UROY) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Uranium Royalty (NASDAQ:UROY – Free Report) from a hold rating to a buy rating in a report issued on Saturday morning. Several other brokerages also recently issued reports on UROY. Raymond James Financial reaffirmed a “market perform” rating on shares of Uranium Royalty in a research report on Wednesday, […]
Maze Therapeutics (NASDAQ:MAZE) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Maze Therapeutics (NASDAQ:MAZE – Free Report) from a sell rating to a hold rating in a research note released on Saturday morning. A number of other equities analysts have also recently commented on MAZE. Wedbush lifted their price objective on shares of Maze Therapeutics from $43.00 to $58.00 and […]
Cognyte Software (NASDAQ:CGNT) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Cognyte Software (NASDAQ:CGNT – Free Report) from a buy rating to a strong-buy rating in a research report sent to investors on Saturday morning. CGNT has been the topic of several other research reports. Lake Street Capital initiated coverage on shares of Cognyte Software in a research report on […]
EHang (NASDAQ:EH) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of EHang (NASDAQ:EH – Free Report) from a sell rating to a hold rating in a research note published on Saturday. A number of other brokerages have also recently weighed in on EH. Bank of America reissued a “buy” rating on shares of EHang in a research note on Thursday, […]
Niagen Bioscience (NASDAQ:NAGE) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Niagen Bioscience (NASDAQ:NAGE – Free Report) from a hold rating to a buy rating in a report issued on Saturday. A number of other brokerages have also recently weighed in on NAGE. Weiss Ratings restated a “hold (c)” rating on shares of Niagen Bioscience in a report on Thursday, […]
Noodles & Company (NASDAQ:NDLS) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Noodles & Company (NASDAQ:NDLS – Free Report) from a sell rating to a hold rating in a research note published on Saturday morning. Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Noodles & Company in a report on Thursday, January 22nd. One analyst has rated the […]
Onespan (NASDAQ:OSPN) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Onespan (NASDAQ:OSPN – Free Report) from a hold rating to a buy rating in a research note released on Saturday morning. Several other research firms have also commented on OSPN. DA Davidson reduced their price objective on Onespan from $13.00 to $12.00 and set a “neutral” rating for the […]
Vericel (NASDAQ:VCEL) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Vericel (NASDAQ:VCEL – Free Report) from a hold rating to a buy rating in a research note issued to investors on Saturday morning. VCEL has been the topic of a number of other reports. Truist Financial cut their price target on shares of Vericel from $50.00 to $45.00 and […]
NPT (NASDAQ:NPT) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of NPT (NASDAQ:NPT – Free Report) from a sell rating to a hold rating in a research report sent to investors on Saturday. Separately, Weiss Ratings assumed coverage on NPT in a report on Friday, January 16th. They set a “sell (e-)” rating for the company. One equities research analyst […]
Biomea Fusion (NASDAQ:BMEA) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Biomea Fusion (NASDAQ:BMEA – Free Report) from a sell rating to a hold rating in a research report report published on Saturday morning. BMEA has been the topic of several other research reports. Weiss Ratings restated a “sell (e+)” rating on shares of Biomea Fusion in a research note […]
Airgain (NASDAQ:AIRG) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Airgain (NASDAQ:AIRG – Free Report) to a hold rating in a research note published on Saturday. Several other analysts have also issued reports on the stock. Lake Street Capital initiated coverage on shares of Airgain in a research report on Wednesday, January 21st. They issued a “buy” rating and […]
Dave & Buster’s Entertainment (NASDAQ:PLAY) Upgraded to “Hold” at Wall Street Zen
Wall Street Zen upgraded shares of Dave & Buster’s Entertainment (NASDAQ:PLAY – Free Report) from a sell rating to a hold rating in a research report report published on Sunday. A number of other equities analysts also recently weighed in on the company. Weiss Ratings reissued a “sell (d)” rating on shares of Dave & […]
Victory Capital (NASDAQ:VCTR) Upgraded to “Buy” at Wall Street Zen
Wall Street Zen upgraded shares of Victory Capital (NASDAQ:VCTR – Free Report) from a hold rating to a buy rating in a report published on Sunday. Other equities research analysts also recently issued reports about the stock. Weiss Ratings reiterated a “buy (b)” rating on shares of Victory Capital in a research note on Wednesday, […]
Pyxis Oncology (NASDAQ:PYXS) Upgraded to “Hold” at Wall Street Zen
Wall Street Zen upgraded shares of Pyxis Oncology (NASDAQ:PYXS – Free Report) from a sell rating to a hold rating in a research note issued to investors on Saturday. Several other research analysts also recently commented on PYXS. HC Wainwright reaffirmed a “buy” rating and set a $7.00 target price on shares of Pyxis Oncology […]
Quantum Biopharma (NASDAQ:QNTM) Upgraded to Hold at Wall Street Zen
Wall Street Zen upgraded shares of Quantum Biopharma (NASDAQ:QNTM – Free Report) from a sell rating to a hold rating in a research note published on Saturday. Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Quantum Biopharma in a research report on Monday, December 29th. One analyst has rated the stock with […]
Sutro Biopharma (NASDAQ:STRO) Upgraded to Hold at Wall Street Zen
Wall Street Zen upgraded shares of Sutro Biopharma (NASDAQ:STRO – Free Report) from a sell rating to a hold rating in a research report report published on Saturday morning. A number of other analysts have also weighed in on the stock. Wells Fargo & Company upgraded shares of Sutro Biopharma from an “equal weight” rating […]
Asure Software (NASDAQ:ASUR) Upgraded to Buy at Wall Street Zen
Wall Street Zen upgraded shares of Asure Software (NASDAQ:ASUR – Free Report) from a hold rating to a buy rating in a research note released on Saturday. Other analysts also recently issued research reports about the stock. Barrington Research reaffirmed an “outperform” rating and set a $15.00 target price on shares of Asure Software in […]
S&T Bancorp (NASDAQ:STBA) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of S&T Bancorp (NASDAQ:STBA – Free Report) from a sell rating to a hold rating in a research note released on Sunday morning. Several other research analysts have also commented on the stock. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of S&T Bancorp in a report on Monday, […]
last updated on 7 Apr 07:44